LONDON (Alliance News) - GlaxoSmithKline said Friday that it had submitted a new drug application to the US Food and Drug Administration for its severe aplastic anaemia treatment Promacta. The treatment is used for patients with the condition who have had an insufficient response to immunos Read More
LONDON (Alliance News) - GlaxoSmithKline PLC Wednesday said a group of executives sold shares for tax purposes in the health company at a price of GBP16.73 per share Monday.<br /><br />Details are as follows.<br /><br /> <table class="af" cellspacing="0" cellpadding="0"><tbody><tr><td class Read More
LONDON (Alliance News) - GlaxoSmithKline PLC Wednesday said Executive Director Moncef Slaoui, General Counsel Dan Troy and Diedre Connelly, a divisional president, had American Depositary Shares withheld for tax purposes at a price of USD55.69 per ADS as part of the company share plan Monday.< Read More
LONDON (Alliance News) - GlaxoSmithKline PLC Tuesday said a group of executives including Roger Connor a divisional president and Philip Thomson, a divisional senior vice president acquired shares while General Counsel James Ford and Executive Director Moncef Slaoui acquired American Depositar Read More
LONDON (Alliance News) - The FTSE 100 closed higher for the sixth consecutive day Friday, closing less than 100 points short of its 2014 opening level as investors shrugged off a host of weaker-than-expected UK and US data releases to ensure the global equity rally continues. The FTSE 100 c Read More
LONDON (Alliance News) - The FTSE 100 closed higher for the sixth consecutive day Friday, closing less than 100 points short of its 2014 opening level as investors shrugged off a host of weaker-than-expected UK and US data releases to ensure the global equity rally continues. The FTSE 100 c Read More
LONDON (Alliance News) - GlaxoSmithKline PLC said Friday that the a group of executives had their number of American Depositary Shares increased following a re-evaluation of the cash element of the notional investment held within the company's 401K plan. The ADSs were issued at USD56.22 each.< Read More
LONDON (Alliance News) - The FTSE 100 looks set to post its sixth consecutive daily rise Friday, as it nears its 2014 high amid a continuing rally in stock markets around the world, largely driven by the recovery of the world's largest economy.<br /><br />The focus in London Friday has been on Read More
LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Thursday. ------- FTSE 100 - WINNERS Royal Bank of Scotland Group, up 2.4%. The bank is preparing a dramatic retrenchment that would see it become a much smalle Read More
LONDON (Alliance News) - The following is a summary of top news stories Friday.<br />----------<br />COMPANIES<br />----------<br /><strong>Royal Dutch Shell</strong> has reached a binding agreement to sell its Australia downstream businesses, excluding Aviation, to Dutch-owned oil trader Vito Read More
LONDON (Alliance News) - The following is a summary of top news stories xxxxday.<br />----------<br />COMPANIES<br />----------<br /><strong>Royal Dutch Shell</strong> has reached a binding agreement to sell its Australia downstream businesses, excluding Aviation, to Dutch-owned oil trader Vit Read More
LONDON (Alliance News) - The FTSE 100 is on track to post its sixth consecutive daily rise Friday, as weaker-than-expected UK retail sales and public finances data failed to dent the recent market positivity. By mid-morning, the FTSE 100 is up 0.4% at 6,836.91, just over 30 points shy of it Read More
LONDON (Alliance News) - The following UK shares received analyst recommendations Friday morning:<br />----------<br /><strong>FTSE 100</strong><br />----------<br />UBS RAISES VODAFONE PRICE TARGET TO 275 (260) PENCE - 'BUY' <br />----------<br />UBS CUTS SMITHS GROUP TO 'SELL' ('NEUTRAL') - Read More
LONDON (Alliance News) - Royal Bank Of Scotland Group is one of the top gainers early Friday on a report that it will shrink dramatically, while GlaxoSmithKline is off to a good start after one of its new drugs was recommended for approval in Europe.<br /><br />The London equity markets are hi Read More
LONDON (Alliance News) - GlaxoSmithKline PLC said Friday that Incruse, a treatment for chronic obstructive pulmonary disease, had been recommended for marketing authorisation by the European Medicines Agency's committee for Medical Products for Human Use, a key step in getting approval for the dr Read More
LONDON (Alliance News) - GlaxoSmithKline PLC said Thursday that its treatment for chronic obstructive pulmonary disease Anoro had been recommended for marketing authorisation from the European Medicines Agency's committee for Medical Products for Human Use. Glaxo expects a final decision on Read More
LONDON (Alliance News) - UK stocks have struggled to get off the ground Wednesday, closing broadly unchanged despite some impressive individual stock performances. The FTSE 100 initially opened higher, continuing a rally that has seen the index retrace most of January's losses. However, after bre Read More